Fibromyalgia Poorly Served By Drug Happy Rheumatologists

The term “fibro” was used to designate soft (or fibrous) tissue involvement and “myalgia” is Latin for “pain”. 

Fibromyalgia was originally thought to be a rheumatologic condition because - like a disease such as rheumatoid arthritis - it is characterized by musculoskeletal pain. But research has since shown that there are no abnormalities in the musculoskeletal system in people with fibromyalgia. Instead, the problem appears to lie in the pain processing pathways of our central nervous system.

The term Fibromyalgia was created by rheumatologist Dr. Frederick Wolfe in 1984 to describe a condition affecting primarily women.

Of course if you’re subscribed to my free Health Matters newsletter, http://drmurphreesnewsletters.com, you read my article about how Dr. Wolfe now denies that fibromyalgia is a real disease-Sad but true.

Before 1990, no guidelines for evaluating and diagnosing fibromyalgia existed. To reduce misdiagnosis and confusion, the American College of Rheumatology (ACR) sponsored a multicenter study to develop these criteria; the results were published in 1990. In 1992, at the Second World Congress on Myofascial Pain and Fibromyalgia, the diagnostic criteria for fibromyalgia were expanded and refined.

Since rheumatologists were the first health specialty to promote and ratify the diagnostic criteria for fibromyalgia, they became the doctors of choice for seeing fibro patients. It didn’t matter that may at least early on had no idea what fibromyalgia was or how to treat it-unfortunately this is often the case today. Many rheumatologists won’t take any new fibro patients or are openly skeptical about the condition.

I believe rheumatologists are the worst possible doctors to manage a fibromyalgia patient’s case. 

Why? There are several reasons -

Because they deal in hard to treat autoimmune diseases, and see patients other doctors don’t want to see, Rheumatologists have a lengthy waiting list-may take 3 months to be seen.

A waiting list of patients can create a lack of empathy for the longwinded, hard to treat fibro patient who needs more than a five-minute office visit every 3 months. “Who cares if you come back I have plenty of other patients waiting in line to be seen.”

Rheumatologist are trained to use drugs, usually incredibly toxic drugs, Methotrexate, gold salts, Plaquenil, Enbrel, etc.

Here is the warning box info for Enbrel:

WARNING

SERIOUS INFECTIONS AND MALIGNANCIES

SERIOUS INFECTIONS.

Patients treated with Enbrel are at increased risk for developing serious infections that may lead to hospitalization or death.

Most patients who developed these infections were taking concomitant immunosuppressant’s such as methotrexate or corticosteroids.

Enbrel should be discontinued if a patient develops a serious infection or sepsis.

Reported infections include:

Active tuberculosis, including reactivation of latent tuberculosis. Patients with tuberculosis have frequently presented with disseminated or extrapulmonary disease. Patients should be tested for latent tuberculosis before Enbrel use and during therapy. Treatment for latent infection should be initiated prior to Enbrel use.

Invasive fungal infections, including histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, and pneumocystosis. Patients with histoplasmosis or other invasive fungal infections may present with disseminated, rather than localized, disease. Antigen and antibody testing for histoplasmosis may be negative in some patients with active infection. Empiric anti-fungal therapy should be considered in patients at risk for invasive fungal infections who develop severe systemic illness.

Bacterial, viral, and other infections due to opportunistic pathogens.

The risks and benefits of treatment with Enbrel should be carefully considered prior to initiating therapy in patients with chronic or recurrent infection.

Patients should be closely monitored for the development of signs and symptoms of infection during and after treatment with Enbrel, including the possible development of tuberculosis in patients who tested negative for latent tuberculosis infection prior to initiating therapy.

MALIGNANCIES

Lymphoma and other malignancies, some fatal, have been reported in children and adolescent patients treated with TNF blockers, including Enbrel.

Scary huh?

The black box warning for Plaquenil is just as scary.

Immunosuppressive medications used by rheumatologists for autoimmune diseases are fraught with danger. That is the reason these drugs are used only by rheumatologists and not by internists, family physicians, or other medical specialists. Rheumatology is a medical specialty developed to prescribe and monitor the side effects of these high-risk medications.

The rheumatologists mentality has been conditioned over the years to continue prescribe more and stronger symptom suppressing drugs. This is a disastrous approach for fibromyalgia patients. Most fibro patients can’t tolerate drugs - they only make them worse. Drugs don’t make you healthy, they can be helpful but they don’t make you healthy. The only way to reverse fibromyalgia is to get healthy!

Using an atomic bomb like Enbrel or Plaquenil to treat fibromyalgia symptoms is not only stupid, it is incredibly dangerous!

Traditional medicine and drug therapy is a dead end for fibro patients. You can read my past blog Traditional Medicine Fails Fibro below or even better:

You can listen to my past First Tuesday of the Month Fibromyalgia Teleconference recordings here:

http://drrodgermurphree.com/fibro-conference-recordings/

My fibro blog- Traditional Medicine Fails Fibromyalgia

http://treatingandbeatingfibroblog.blogspot.com/2010/12/traditional-medicine-offers-little-for.html

I'll Take My Chances With Complementary Medicine

Over 700,000 Americans die each year from government sanctioned, FDA approved, AMA sponsored medicine.

Iatrogenic, or doctor induced, illnesses take the lives of 783,936 American each year. This makes conventional medicine the number one killer in the United States, ahead of heart disease and cancer. And, beware that as few as 5% of iatrogenic events are ever reported.

This implies that iatrogenic deaths are much higher and would be equivalent to six jumbo jets falling out of the sky each day. Now that’s news!

An October 2003 JAMA study from the US government’s Agency for Healthcare Research and Quality (AHRQ) reported 32,000, mostly surgery-related, deaths costing $9 billion and resulting in 2.4 million extra hospital days in 2000. Americans submit to over 600,000 bypass surgeries each year. The Journal of the American Medical Association reports that up to 10% of bypass patients die from the surgery. Yet, the National Institutes of Health has estimated that 90% of Americans who undergo bypass surgery receive no benefits. Another study involving 14 major heart hospitals around the world showed that one-third of all heart bypass surgeries were unnecessary and actually increased the risk of death.

Americans using FDA sanctioned drugs, as directed, are dying at the rate of one every three to five minutes. In fact, the average American has a 26% chance of being hospitalized from a drug injury from the effects of a lifetime of drug taking. Of the 30 million people admitted to hospitals each year, approximately ten percent, or 3 million, are admitted specifically because of adverse drug reactions. In 1995, a JAMA report noted that, “…approximately 280,000 die annually as a result of these injuries.” And to top it off, hospital born infections kill another 26,000 (conservative estimate) patients each year. The General Accounting Office reports, “of the 198 drugs approved by the FDA between 1976 and 1985, 102 of them or 51% had serious post approval risks including heart failure, myocardial infarction, respiratory failure, seizures, and kidney failure.

The FDA estimates that NSAIDS cause 200,000 cases of gastric bleeding annually, leading to 10,000 to 20,000 deaths. Calcium channel blockers increase the risk of stroke by five-fold.

Americans take over 5 billion sleeping pills each year. And each year, 15,000 Americans die from these same sleeping pills. The heart drug Digoxin causes over 28,000 cases of life-threatening or fatal adverse reactions each year.

The very drugs that are being used to treat various illnesses are causing more American deaths in one year than occurred in the entire Vietnam War! Yet, in spite of the fact that these FDA approved drugs are killing over 100,000 Americans each year, people still believe health comes from a doctor prescribed pill bottle. Annual spending on drugs continues to grow by 12% or more each year. The public and the medical profession have been brain-washed into believing drug therapy is a safe and effective way to “cure” every ailment known to man. This starts at an early age as our kids become jaded and used  to the idea of lining up for the school nurse to dispense their Ritalin and other psychotropic drugs. To safeguard their stranglehold on public perception, the pharmaceutical industry makes sure doctors are thoroughly duped with half-truths and pseudo-science about the newest, greatest wonder drugs.

In 2001, drug companies paid for over 60% of the costs of all doctors’ continuing education classes. And over 80,000 drug reps give away $11 billion worth of samples each year. There is now one drug rep for every doctor in the United States.

However, today’s latest greatest drug is often tomorrows widow maker. Does Rezulin, Zelnorm, Baycol, Fen-Phen, Propulsid, Avandia, Vioxx, and Bextra ring any bells?

Vioxx alone has been linked to 27,000 cases of heart attack. The diabetes drug Avandia, increases heart attack risk by 43% and increases risk of death from heart disease by 64%. Dr. David Graham of the Food and Drug Administration estimates that Avandia may have caused 30,000 to 140,000 heart attacks or deaths since it was introduced in the U.S. in 1999.


Despite the periodic yellow journalism that warns us against the dangers of alternative medicine, given the risks associated with traditional medicine, I'm happy to take my chances with complementary medicine.